NSAIDs like ibuprofen not tied to severe COVID-19, death

The Center for Infectious Disease Research and Policy at the University of Minnesota reports on NSAIDs and COVID-19.

Contrary to early reports, the use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen is not associated with severe COVID-19 disease or death, according to a cohort study published yesterday in PLOS One.

There were no significant differences between NSAID users and non-users in terms of 30-day death rate (6.3% of NSAID users vs 6.1% of non-users), hospitalization (24.5% vs 21.2%), or intensive care unit (ICU) admission (4.9% vs 4.7%).